David P Bonita - Net Worth and Insider Trading

David P Bonita Net Worth

The estimated net worth of David P Bonita is at least $376 Million dollars as of 2024-06-05. David P Bonita is the Director of Loxo Oncology Inc and owns about 941,000 shares of Loxo Oncology Inc (LOXO) stock worth over $221 Million. David P Bonita is the Director, 10% Owner of Third Harmonic Bio Inc and owns about 5,779,071 shares of Third Harmonic Bio Inc (THRD) stock worth over $77 Million. David P Bonita is also the Director, 10% Owner of Prelude Therapeutics Inc and owns about 10,646,056 shares of Prelude Therapeutics Inc (PRLD) stock worth over $38 Million. Besides these, David P Bonita also holds Imara Inc (IMRA) , SI-BONE Inc (SIBN) , Acutus Medical Inc (AFIB) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , ViewRay Inc (VRAYQ) , Tricida Inc (TCDAQ) . Details can be seen in David P Bonita's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Bonita has not made any transactions after 2023-05-22 and currently still holds the listed stock(s).

Transaction Summary of David P Bonita

David P Bonita Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David P Bonita owns 11 companies in total, including Prelude Therapeutics Inc (PRLD) , Acutus Medical Inc (AFIB) , and Repare Therapeutics Inc (RPTX) among others .

Click here to see the complete history of David P Bonita’s form 4 insider trades.

Insider Ownership Summary of David P Bonita

Ticker	Comapny	Transaction Date	Type of Owner
PRLD	Prelude Therapeutics Inc	2023-05-22	director & 10 percent owner
AFIB	Acutus Medical Inc	2021-07-19	director & 10 percent owner
RPTX	Repare Therapeutics Inc	2021-09-07	director
		2022-11-25	director & 10 percent owner
		2021-07-16	director & 10 percent owner
		2018-10-19	director
		2017-12-08	director
		2017-01-18	director & 10 percent owner
		2021-03-30	director
		2022-09-19	director & 10 percent owner
		2020-03-11	director & 10 percent owner

David P Bonita Latest Holdings Summary

David P Bonita currently owns a total of 10 stocks. Among these stocks, David P Bonita owns 941,000 shares of Loxo Oncology Inc (LOXO) as of December 8, 2017, with a value of $221 Million and a weighting of 58.67%. David P Bonita owns 5,779,071 shares of Third Harmonic Bio Inc (THRD) as of September 19, 2022, with a value of $77 Million and a weighting of 20.36%. David P Bonita also owns 10,646,056 shares of Prelude Therapeutics Inc (PRLD) as of May 22, 2023, with a value of $38 Million and a weighting of 10.07%. The other 7 stocks Imara Inc (IMRA) , SI-BONE Inc (SIBN) , Acutus Medical Inc (AFIB) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , ViewRay Inc (VRAYQ) , Tricida Inc (TCDAQ) have a combined weighting of 10.9% among all his current holdings.

Latest Holdings of David P Bonita

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LOXO	Loxo Oncology Inc	2017-12-08	941,000	234.66	220,815,060
THRD	Third Harmonic Bio Inc	2022-09-19	5,779,071	13.26	76,630,481
PRLD	Prelude Therapeutics Inc	2023-05-22	10,646,056	3.56	37,899,959
IMRA	Imara Inc	2021-07-16	4,199,068	6.32	26,538,110
SIBN	SI-BONE Inc	2018-10-19	985,368	13.75	13,548,810
AFIB	Acutus Medical Inc	2021-07-19	6,553,408	0.05	349,297
RPTX	Repare Therapeutics Inc	2021-09-07	96,190	3.53	339,551
IKNA	Ikena Oncology Inc	2021-03-30	130,924	1.74	227,808
VRAYQ	ViewRay Inc	2017-01-18	89,225	0.00	1
TCDAQ	Tricida Inc	2022-11-25	0	0.00	0

Holding Weightings of David P Bonita

David P Bonita Form 4 Trading Tracker

According to the SEC Form 4 filings, David P Bonita has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 250,000 shares on December 8, 2017, which brought David P Bonita around $21 Million.

According to the SEC Form 4 filings, David P Bonita has made a total of 1 transactions in Third Harmonic Bio Inc (THRD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Third Harmonic Bio Inc is the acquisition of 300,000 shares on September 19, 2022, which cost David P Bonita around $5 Million.

According to the SEC Form 4 filings, David P Bonita has made a total of 2 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Prelude Therapeutics Inc is the acquisition of 869,565 shares on May 22, 2023, which cost David P Bonita around $5 Million.

More details on David P Bonita's insider transactions can be found in the Insider Trading History of David P Bonita table.

Insider Trading History of David P Bonita

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David P Bonita Trading Performance

GuruFocus tracks the stock performance after each of David P Bonita's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Bonita is 15.99%. GuruFocus also compares David P Bonita's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Bonita within 3 months outperforms 5 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David P Bonita's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David P Bonita

Average Return

Average return per transaction

Outperforming Transactions

4 out of 16 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	1.52
Relative Return to S&P 500(%)	-1.46

David P Bonita Ownership Network

Ownership Network List of David P Bonita

No Data

Ownership Network Relation of David P Bonita

David P Bonita Owned Company Details

What does Prelude Therapeutics Inc do?

Who are the key executives at Prelude Therapeutics Inc?

David P Bonita is the director & 10 percent owner of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & President & CEO Krishna Vaddi , Chief Legal Counsel & Corp Sec. Bryant David Lim , and Chief Financial Officer Laurent Chardonnet .

Prelude Therapeutics Inc (PRLD) Insider Trades Summary

Over the past 18 months, David P Bonita made 1 insider transaction in Prelude Therapeutics Inc (PRLD) with a net purchase of 869,565. Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 32,944 shares made by Krishna Vaddi , a net purchase of 15,000 shares made by Laurent Chardonnet , and a net purchase of 869,565 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,280 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,789,474 shares were bought by its insiders, resulting in a net purchase of 1,776,194 shares.

Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prelude Therapeutics Inc Insider Transactions

No Available Data

What does Acutus Medical Inc do?

Who are the key executives at Acutus Medical Inc?

David P Bonita is the director & 10 percent owner of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .

Acutus Medical Inc (AFIB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acutus Medical Inc Insider Transactions

No Available Data

What does Repare Therapeutics Inc do?

Who are the key executives at Repare Therapeutics Inc?

David P Bonita is the director of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .

Repare Therapeutics Inc (RPTX) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Repare Therapeutics Inc Insider Transactions

No Available Data

What does Tricida Inc do?

Who are the key executives at Tricida Inc?

David P Bonita is the director & 10 percent owner of Tricida Inc. Other key executives at Tricida Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Venrock Healthcare Capital Partners Ii, L.p. , and 10 percent owner & other: *possible member of 10% group Sibling Capital Fund Ii-b L.p. .

Tricida Inc (TCDAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tricida Inc (TCDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tricida Inc (TCDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tricida Inc (TCDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tricida Inc Insider Transactions

No Available Data

What does Imara Inc do?

Who are the key executives at Imara Inc?

David P Bonita is the director & 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .

Imara Inc (IMRA) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in Imara Inc (IMRA). Other recent insider transactions involving Imara Inc (IMRA) include a net sale of 2,590,000 shares made by Braden Michael Leonard , a net purchase of 29,899 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 11,313 shares made by Rahul D. Ballal .

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,604,909 shares of Imara Inc (IMRA) were sold and 29,899 shares were bought by its insiders, resulting in a net sale of 2,575,010 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Imara Inc Insider Transactions

No Available Data

What does SI-BONE Inc do?

Who are the key executives at SI-BONE Inc?

David P Bonita is the director of SI-BONE Inc. Other key executives at SI-BONE Inc include Chief Commercial Officer Anthony J Recupero , director & Chairman & President & CEO Jeffrey W Dunn , and Chief Financial Officer Anshul Maheshwari .

SI-BONE Inc (SIBN) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in SI-BONE Inc (SIBN). Other recent insider transactions involving SI-BONE Inc (SIBN) include a net sale of 361,756 shares made by Jeffrey W Dunn , a net sale of 51,210 shares made by Anthony J Recupero , and a net sale of 22,401 shares made by Anshul Maheshwari .

In summary, during the past 3 months, insiders sold 22,856 shares of SI-BONE Inc (SIBN) in total and bought 0 shares, with a net sale of 22,856 shares. During the past 18 months, 535,349 shares of SI-BONE Inc (SIBN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 535,349 shares.

SI-BONE Inc (SIBN)'s detailed insider trading history can be found in Insider Trading Tracker table.

SI-BONE Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

David P Bonita is the director of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does ViewRay Inc do?

Who are the key executives at ViewRay Inc?

David P Bonita is the director & 10 percent owner of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .

ViewRay Inc (VRAYQ) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .

In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,529,227 shares of ViewRay Inc (VRAYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,529,227 shares.

ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

ViewRay Inc Insider Transactions

No Available Data

What does Ikena Oncology Inc do?

Who are the key executives at Ikena Oncology Inc?

David P Bonita is the director of Ikena Oncology Inc. Other key executives at Ikena Oncology Inc include CFO & Head of Corp. Dev. Jotin Marango , Principal Accounting Officer Francisco Oliveira , and Chief Scientific Officer Xiaoyan Michelle Zhang .

Ikena Oncology Inc (IKNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ikena Oncology Inc (IKNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ikena Oncology Inc (IKNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ikena Oncology Inc (IKNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ikena Oncology Inc Insider Transactions

No Available Data

What does Third Harmonic Bio Inc do?

Who are the key executives at Third Harmonic Bio Inc?

David P Bonita is the director & 10 percent owner of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include director & CEO Natalie C. Holles , Chief Administrative Officer Julie Person , and Chief Medical Officer Edward R. Conner .

Third Harmonic Bio Inc (THRD) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,780 shares made by Natalie C. Holles , a net sale of 24,620 shares made by , and a net sale of 13,970 shares made by Julie Person .

In summary, during the past 3 months, insiders sold 59,507 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 59,507 shares. During the past 18 months, 77,160 shares of Third Harmonic Bio Inc (THRD) were sold and 214,063 shares were bought by its insiders, resulting in a net purchase of 136,903 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Third Harmonic Bio Inc Insider Transactions

No Available Data

What does Enliven Therapeutics Inc do?

Who are the key executives at Enliven Therapeutics Inc?

David P Bonita is the director & 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include director & Chief Scientific Officer Joseph P Lyssikatos , director & President and CEO Samuel Kintz , and Chief Financial Officer Benjamin Hohl .

Enliven Therapeutics Inc (ELVN) Insider Trades Summary

Over the past 18 months, David P Bonita made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 155,709 shares made by Samuel Kintz , a net sale of 138,000 shares made by Joseph P Lyssikatos , and a net sale of 57,867 shares made by Anish Patel .

In summary, during the past 3 months, insiders sold 2,392,055 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 2,392,055 shares. During the past 18 months, 4,549,466 shares of Enliven Therapeutics Inc (ELVN) were sold and 622 shares were bought by its insiders, resulting in a net sale of 4,548,844 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enliven Therapeutics Inc Insider Transactions

No Available Data

David P Bonita Mailing Address

Above is the net worth, insider trading, and ownership report for David P Bonita. You might contact David P Bonita via mailing address: C/o Orbimed Advisors Llc, 601 Lexington Avenue, 54th Floor, New York Ny 10022.

Discussions on David P Bonita

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.